Apple plans to disable the blood oxygen measurement function of the Apple Watch in the US after the ban on sales in the country
Apple plans to disable the blood oxygen measurement function of the Apple Watch in the US to avoid a US International Trade Commission (ITC) ban imposed over a patent dispute with medical company Masimo.
US Customs and Border Protection has determined that Apple’s product redesign is outside the scope of the ITC’s ruling. However, these changes consist only in the disconnection of the blood oxygen measurement sensor from the new devices sold.
In this way, Apple will be able to resume sales of the Apple Watch Series 9 and Watch Ultra 2.
The ITC found Apple infringing Masimo’s patent in January of last year. In October, the regulator issued an order barring Apple from importing a number of Apple Watch models for infringing two Masimo patents related to blood oxygen measurement technology. Two months later, the corporation was forced to stop selling two models of smart watches in the United States.
9to5mac has speculated that Apple will disable the oxygen monitoring feature on the Apple Watch Series X amid a patent dispute.
The corporation explained that its updated products definitely do not include the function of measuring oxygen in the blood. Currently, the US Court of Appeals continues to consider the reason for the ban on the sale of the Apple Watch. The ITC criticized the company’s attempt to appeal the ruling, stressing that the admitted infringer requires permission to continue infringing the claimed patents.